Published on 02 July 2012
Pharmacovigilance of biosimilars: challenges and possible solutions
Author(s): Sabine MJM Straus, MD, PhD, Thijs J Giezen, PharmD, PhD, MSc
biologicals, biosimilars, immunogenicity, pharmacovigilance, traceability
DOI: 10.5639/gabij.2012.0103-4.033
16.896 views